Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

Cited by (1,004)

Items 901–1,000 of 1,004

1. Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease
   Enes Akyüz, Feyza Şule Aslan, Enise Gokce, Oguzkan Ilmaz, Feyzullah Topcu, Seda Kakac · 2024 · European Journal of Neuroscience
2. A genome-wide analysis of the shared genetic risk architecture of complex neurological and psychiatric disorders
   Olav Bjerkehagen Smeland, Gleda Kutrolli, Shahram Bahrami, Vera Fominykh, Nadine Parker, Julian Fuhrer, Guy Hindley, Linn Nilsen Rødevand, Piotr Pawel Jaholkowski, Markos Tesfaye et al. · 2025 · Nature Neuroscience
3. Genetic variation in neurodegenerative diseases and its accessibility in the model organism Caenorhabditis elegans
   Yiru A. Wang, Jan E. Kammenga, Simon Crawford Harvey · 2017 · Human Genomics
4. A systematic review and integrative approach to decode the common molecular link between levodopa response and Parkinson’s disease
   Debleena Guin, Manish Mishra, Puneet Talwar, Chitra Rawat, Suman S. Kushwaha, Shrikant Kukreti, Ritushree Kukreti · 2017 · BMC Medical Genomics
5. Identification of novel epigenetic abnormalities as sputum biomarkers for lung cancer risk among smokers and COPD patients
   Mathewos Tessema, D. Tassew, Christin M. Yingling, Kieu Do, Maria A. Picchi, Guodong Wu, Hans V. Petersen, Scott H. Randell, Yong Lin, Steven A. Belinsky et al. · 2020 · Lung Cancer
6. Association Between Glucocerebrosidase Mutations and Parkinson's Disease in Ireland
   Diana A. Olszewska, Allan J. McCarthy, Alexandra I. Soto‐Beasley, Ronald L. Walton, Brian Magennis, Russell Lewis McLaughlin, Orla M. Hardiman, Owen A. Ross, Timothy Lynch · 2020 · Frontiers in Neurology
7. LRRK2 and Protein Aggregation in Parkinson’s Disease: Insights From Animal Models
   Dylan J. Dues, Darren J. Moore · 2020 · Frontiers in Neuroscience
8. Trans‐Ethnic Fine‐Mapping of the Major Histocompatibility Complex Region Linked to Parkinson's Disease
   Tatsuhiko Naito, Wataru Satake, Kotaro Ogawa, Suzuki Ken, Jun Hirata, Jia Nee Foo, Eng‐King Tan, Tatsushi Toda, Yukinori Okada · 2021 · Movement Disorders
9. Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND data
   Matthew Brendel, Chang Su, Yu Hou, Claire Henchcliffe, Fei Wang · 2021 · npj Parkinson s Disease
10. LRRK2: Genetic mechanisms vs genetic subtypes
    Ignacio Fernandez Mata, Philippe A. Salles, Mario Cornejo‐Olivas, Paula Saffie Awad, Owen A. Ross, Xylena Reed, Sara Bandrés‐Ciga · 2023 · Handbook of clinical neurology
11. Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview
    Vidal Yahya, Alessio Di Fonzo, Edoardo Monfrini · 2023 · International Journal of Molecular Sciences
12. Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC‐Based Models
    Rubén Fernández‐Santiago, Mario Ezquerra · 2015 · Stem Cells International
13. Association of GCH1 and MIR4697 , but not SIPA1L2 and VPS13C polymorphisms, with Parkinson's disease in Taiwan
    Chiung‐Mei Chen, Yi‐Chun Chen, Mu-Chun Chiang, Hon‐Chung Fung, Kuo‐Hsuan Chang, Guey‐Jen Lee‐Chen, Yih‐Ru Wu · 2015 · Neurobiology of Aging
14. STK39, But Not BST1, HLA-DQB1, and SPPL2B Polymorphism, Is Associated With Han-Chinese Parkinson's Disease in Taiwan
    Kuo‐Hsuan Chang, Yih‐Ru Wu, Yi-Chun Chen, Hon‐Chung Fung, Guey‐Jen Lee‐Chen, Chiung‐Mei Chen · 2015 · Medicine
15. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson’s disease
    A. Emelyanov, Darya G. Kulabukhova, Luiza A. Garaeva, Konstantin A. Senkevich, Elena V. Verbitskaya, Mikhail A. Nikolaev, Pavel A. Andoskin, Alena E. Kopytova, I. V. Milyukhina, Аndrey F. Yakimovskii et al. · 2018 · Journal of the Neurological Sciences
16. Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
    Silvia Paciotti, Leonardo Gatticchi, Tommaso Beccari, Lucilla Parnetti · 2019 · Clinica Chimica Acta
17. Proteomics-Based Monitoring of Pathway Activity Reveals that Blocking Diacylglycerol Biosynthesis Rescues from Alpha-Synuclein Toxicity
    Martin Soste, Konstantina Charmpi, Fabienne Lampert, Juan Gerez, Marc van Oostrum, Liliana Malinovska, Paul J. Boersema, Natalia Cecilia Prymaczok, Roland Riek, Matthias Peter et al. · 2019 · Cell Systems
18. The dual role of c‐src in cell‐to‐cell transmission of α‐synuclein
    Yu Ree Choi, Jae‐Bong Kim, Seo‐Jun Kang, Hye Rin Noh, Ilo Jou, Eun-hye Joe, Sang Myun Park · 2020 · EMBO Reports
19. The shared genetic risk architecture of neurological and psychiatric disorders: a genome-wide analysis
    Olav Bjerkehagen Smeland, Gleda Kutrolli, Shahram Bahrami, Vera Fominykh, Nadine Parker, Guy Hindley, Linn Nilsen Rødevand, Piotr Pawel Jaholkowski, Markos Tesfaye, Pravesh Parekh et al. · 2023 · medRxiv
20. The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease
    Runing Yang, Ge Gao, Hui Min Yang · 2022 · Frontiers in Aging Neuroscience
21. Explainable AI for Parkinson’s disease prediction: A machine learning approach with interpretable models
    Adebimpe Omolayo Esan, David B. Olawade, Afeez Adekunle Soladoye, Bolaji A Omodunbi, Ibrahim Adeyanju, Nicholas Aderinto · 2025 · Current Research in Translational Medicine
22. Genetic association of RIT2 rs12456492 polymorphism and Parkinson’s disease susceptibility in Asian populations: a meta-analysis
    Yanjun Lu, Wei Liu, Kun Tan, Jing Peng, Yaowu Zhu, Xiong Wang · 2015 · Scientific Reports
23. Mutation screening and burden analysis of VPS13C in Chinese patients with early-onset Parkinson's disease
    Xiaojing Gu, Chunyu Li, Yongping Chen, Ruwei Ou, Bei Cao, Qianqian Wei, Yanbing Hou, Lingyu Zhang, Wei Song, Bi Zhao et al. · 2020 · Neurobiology of Aging
24. Downregulation of astroglial glutamate transporter GLT-1 in the lateral habenula is associated with depressive-like behaviors in a rat model of Parkinson's disease
    Shuxuan Lyu, Yuan Guo, Li Zhang, Guoyi Tang, Ruotong Li, Jie Yang, Shasha Gao, Wenjuan Li, Jian Liu · 2021 · Neuropharmacology
25. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson’s disease
    Soojin Park, Uram Jin, Sang Myun Park · 2021 · PLoS Pathogens
26. Blood RNA biomarkers in prodromal PARK4 and REM sleep behavior disorder show role of complexin-1 loss for risk of Parkinson's disease
    Suna Lahut, Suzana Gispert, Özgür Ömür, Candan Depboylu, Kay Seidel, Jorge Antolio Domínguez-Bautista, Nadine Brehm, Hülya Tireli, Karl Hackmann, Caroline Pirkevi Cetinkaya et al. · 2017 · Disease Models & Mechanisms
27. Rare GCH1 heterozygous variants contributing to Parkinson’s disease
    Qian Xu, Kai Li, Qiying Sun, Dongxue Ding, Yuwen Zhao, Nannan Yang, Yang Luo, Zhenhua Liu, Yuan Zhang, Chunrong Wang et al. · 2017 · Brain
28. A Novel p.Glu298Lys Mutation in the ACMSD Gene in Sporadic Parkinson’s Disease
    Dolores Vilas, Rubén Fernández‐Santiago, Elena Sanchez, Luis J. Azcona, Meritxell Santos-Montes, Pilar Casquero, Lucía Argandoña, EDUARDO S. TOLOSA, Coro Paisán‐Ruiz · 2017 · Journal of Parkinson s Disease
29. Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease
    Koji Kasanuki, Michael G. Heckman, Nancy N. Diehl, Melissa Erin Murray, Shunsuke Koga, Alexandra I. Soto, Owen A. Ross, Dennis W. Dickson · 2017 · Movement Disorders
30. Utilization of the CRISPR-Cas9 Gene Editing System to Dissect Neuroinflammatory and Neuropharmacological Mechanisms in Parkinson’s Disease
    Jie Denny Luo, Piyush Padhi, Huajun Jin, Vellareddy Anantharam, Gary D. Zenitsky, Qian Wang, Auriel A. Willette, Anumantha G. Kanthasamy, Anumantha G. Kanthasamy · 2019 · Journal of Neuroimmune Pharmacology
31. Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration
    Fred Yeboah, Taeeun Kim, Anke Bill, Ulf Dettmer · 2019 · Neurobiology of Disease
32. A microglia clonal inflammatory disorder in Alzheimer’s disease
    Vicario, Rocio, Fragkogianni, Stamatina, Weber, Leslie, Lazarov, Tomi, Hu, Yang, Hayashi, Samantha Y, Craddock, Barbara, Socci, Nicholas D, Alberdi, Araitz, Baako, Ann et al. · 2025 · eLife
33. The Neuroprotective Role of Protein Quality Control in Halting the Development of Alpha-Synuclein Pathology
    Manecka, Destiny-Love, Vanderperre, Benoît, Fon, Edward A., Durcan, Thomas M. · 2017 · Frontiers in Molecular Neuroscience
34. Recent advances in targeting LRRK2 for Parkinson’s disease treatment
    Mahsa Karami, Pantea Majma Sanaye, Atousa Ghorbani, Roshanak Amirian, Pouya Goleij, Mehregan Babamohamadi, Zhila Izadi · 2025 · Journal of Translational Medicine
35. CNS disease models with human pluripotent stem cells in the CRISPR age
    Julien Muffat, Yun Li, Rudolf Jaenisch · 2016 · Current Opinion in Cell Biology
36. Modeling the genetic complexity of Parkinson's disease by targeted genome edition in iPS cells
    Carles Calatayud, Giulia Carola, Antonella Consiglio, Ángel Raya · 2017 · Current Opinion in Genetics & Development
37. Neuronal Differentiation of LUHMES Cells Induces Substantial Changes of the Proteome
    Johanna Tüshaus, Evans Sioma Kataka, Jan Maciej Zaucha, Dmitrij Frishman, Stephan A. Müller, Stefan F. Lichtenthaler · 2020 · PROTEOMICS
38. Metabolomics in Parkinson's disease
    Jacopo Troisi, Annamaria Landolfi, Pierpaolo Cavallo, Francesca Marciano, Paolo Barone, Marianna Amboni · 2020 · Advances in clinical chemistry
39. Shared Genetics of Multiple System Atrophy and Inflammatory Bowel Disease
    Alexey A. Shadrin, Sören Mucha, David Ellinghaus, Mary B. Makarious, Cornelis Blauwendraat, Ashwin Ashok Kumar Sreelatha, Antonio Heras‐Garvin, Jinhui Ding, Monia Benhamed Hammer, Alexandra Foubert‐Samier et al. · 2020 · Movement Disorders
40. Transmembrane 163 (TMEM163) Protein: A New Member of the Zinc Efflux Transporter Family
    Daniel J. Styrpejko, Math P. Cuajungco · 2021 · Biomedicines
41. Small molecule therapeutics for neuroinflammation-mediated neurodegenerative disorders
    Silke Miller, María-Jesús Blanco · 2021 · RSC Medicinal Chemistry
42. Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis
    Wei Quan, Jia Li, Xiya Jin, Li Liu, Qinghui Zhang, Yidan Qin, Xiaochen Pei, Jiajun Chen · 2021 · Parkinson s Disease
43. Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
    Jennifer A. Macdonald, John Li Chen, Masami Masuda‐Suzukake, Manuel Schweighauser, Zane Jaunmuktane, Thomas T. Warner, Janice L. Holton, Annabelle Grossman, Richard Berks, Isabelle Lavenir et al. · 2021 · Acta Neuropathologica Communications
44. LRRK2 signaling in neurodegeneration: two decades of progress
    Lucia Iannotta, Elisa Greggio · 2021 · Essays in Biochemistry
45. Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches
    Yue Ming Huang, Jun Wei, Antony A. Cooper, Margaret J. Morris · 2022 · Genes & Diseases
46. Transgenic Mouse Models for the Study of Neurodegenerative Diseases
    Alba Marín‐Moreno, Sara Canoyra, Natalia Fernández‐Borges, Juan Carlos Espinosa, Juan María Torres · 2023 · Frontiers in Bioscience-Landmark
47. Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue
    Christina Victoria Isabella Tauber, Sigrid C. Schwarz, Thomas W. Rösler, Thomas Arzberger, Steve Gentleman, Otto Windl, Mandy Krumbiegel, André Reis, Viktoria Ruf, Jochen Wolfgang Herms et al. · 2023 · Acta Neuropathologica Communications
48. C-reactive protein as the biomarker of choice to monitor the effects of exercise on inflammation in Parkinson’s disease
    Niyati Mehta, Nijee Luthra, Daniel M. Corcos, Giamila Fantuzzi · 2023 · Frontiers in Immunology
49. Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies
    Zhiguo Sun, Boris Kantor, Ornit Chiba‐Falek · 2023 · Molecular Therapy — Nucleic Acids
50. Neuronal MAPT expression is mediated by long-range interactions with cis-regulatory elements
    Brianne B. Rogers, Ashlyn G. Anderson, Shelby N. Lauzon, M. Natalie Davis, Rebecca M. Hauser, Sydney C. Roberts, Iván Rodríguez-Nunez, Katie Trausch‐Lowther, Erin A. Barinaga, Paige I. Hall et al. · 2024 · The American Journal of Human Genetics
51. M endelian R andomization — the K ey to U nderstanding A spects of P arkinson's D isease C ausation?
    Alastair John Noyce, Mike A. Nalls · 2015 · Movement Disorders
52. Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson’s Disease
    Ju‐Hee Kang · 2016 · Journal of Movement Disorders
53. LRRK2 Phosphorylation: Behind the Scenes
    Tina De Wit, Veerle Baekelandt, Evy Lobbestael · 2018 · The Neuroscientist
54. Identifying Genetic Risk Factors for Alzheimer's Disease via Shared Tree-guided Feature Learning across Multiple Tasks
    Weizhong Zhang, Tingjin Luo, Shuang Qiu, Jieping Ye, Deng Cai, Xiaofei He, Jie Wang · 2018 · IEEE Transactions on Knowledge and Data Engineering
55. Gut microbiome-based secondary metabolite biosynthetic gene clusters detection in Parkinson’s disease
    Shengqin Wang, Nan Li, Hui-Xi Zou, Mingjiang Wu · 2018 · Neuroscience Letters
56. New therapeutic approaches to target alpha-synuclein in Parkinson's disease: The role of immunotherapy
    Tamara Fernández‐Valle, Iñigo Gabilondo, Juan Carlos Gómez‐Esteban · 2019 · International review of neurobiology
57. Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy
    Fauzia Nazam, Sibhghatulla Shaikh, Nazia Nazam, Abdulaziz Alshahrani, Gulam Mustafa Hasan, Md. Imtaiyaz Hassan · 2021 · Molecular and Cellular Biochemistry
58. Association of Parkinson disease age of onset with DRD2, DRD3 and GRIN2B polymorphisms
    Anhar Hassan, Michael G. Heckman, J. Eric Ahlskog, Zbigniew K. Wszołek, Daniel Serie, Ryan J. Uitti, Jay A. van Gerpen, Michael S. Okun, Sruti Rayaprolu, Owen A. Ross · 2015 · Parkinsonism & Related Disorders
59. Comprehensive promoter level expression quantitative trait loci analysis of the human frontal lobe
    Cornelis Blauwendraat, Margherita Francescatto, Jesse Raphael Gibbs, Iris E. Jansen, Javier Simón‐Sánchez, Dena G. Hernandez, Allissa Dillman, Andrew Singleton, Mark Cookson, Patrizia Rizzu et al. · 2016 · Genome Medicine
60. Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-Americans
    Jing Dong, Annah B. Wyss, Jingyun Yang, T. Ryan Price, Aude Nicolas, Mike A. Nalls, Greg J. Tranah, Nora Franceschini, Zongli Xu, Claudia Schulte et al. · 2016 · Molecular Neurobiology
61. Aerobic exercise-induced changes in fluid biomarkers in Parkinson’s disease
    Nijee Luthra, Niyati Mehta, Miranda J. Munoz, Giamila Fantuzzi, Guillaume J. Lamotte, Jacob M. Haus, Nikolaus R. McFarland, Malú G. Tansey, Paulina González-Latapí, Gabriela Caraveo et al. · 2025 · npj Parkinson s Disease
62. Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE‐ε4/TOMM40 long poly‐T repeat allele variants
    Inga Prokopenko, Gentaro Miyakawa, Bang Zheng, Jani Heikkinen, Daniela Petrova, Chinedu Theresa Udeh‐Momoh, Annique Claringbould, Juliane Neumann, Hazal Haytural, Marika Kaakinen et al. · 2019 · Alzheimer s & Dementia Translational Research & Clinical Interventions
63. Epigenome‐wide analyses identify DNA methylation signatures of dementia risk
    Rosie May Walker, Mairead L. Bermingham, Kadi Vaher, Stewart W. Morris, Toni‐Kim Clarke, Andrew D. Bretherick, Yanni Zeng, Carmen Amador, Konrad Rawlik, Kalyani Pandya et al. · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
64. Functional genomic analyses uncover APOE-mediated regulation of brain and cerebrospinal fluid beta-amyloid levels in Parkinson disease
    Laura Ibáñez, Jorge Alberto Bahena, Chengran Yang, Umber Dube, Fabiana Farias, John Budde, Kristy Bergmann, Carol Brenner-Webster, John C. Morris, Richard J. Perrin et al. · 2020 · Acta Neuropathologica Communications
65. Metal Exposure and SNCA rs356219 Polymorphism Associated With Parkinson Disease and Parkinsonism
    Roberto G. Lucchini, Stefano Guazzetti, Stefano Renzetti, Karin Bröberg, Margherita Caci, Loredana Covolo, Patrizia Crippa, Umberto Gelatti, Dana Hashim, Manuela Oppini et al. · 2020 · Frontiers in Neurology
66. Reconstruction of gene network associated with Parkinson disease for gene targets search
    Yuriy Lvovich Orlov, A. G. Galieva, N.G. Orlova, E.N. Ivanova, Y.A. Mozyleva, Anastasia A. Anashkina · 2021 · Biomeditsinskaya Khimiya
67. Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways
    Sophia R.L. Vieira, Anthony H.V. Schapira · 2021 · Free Radical Biology and Medicine
68. Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
    Myung Jun Lee, Kyoungjune Pak, Han‐Kyeol Kim, Kelly Nicole Holohan Nudelman, Jong Hun Kim, Yun Hak Kim, Junho Kang, Min Seok Baek, Chul Hyoung Lyoo · 2021 · npj Parkinson s Disease
69. Effects of ulcerative colitis and Crohn’s disease on neurodegenerative diseases: A Mendelian randomization study
    Hong Li, Zheng Wen · 2022 · Frontiers in Genetics
70. Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases
    Judith Potashkin, Jose Santiago, James P. Quinn · 2023 · International Journal of Molecular Sciences
71. Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease
    Danuta Sastre, Faria Zafar, C. Alejandra Morato Torres, Desiree Piper, Deniz Kirik, Laurie H. Sanders, Lei S. Qi, Birgitt Schüle · 2023 · Scientific Reports
72. Systemic inflammation and risk of Parkinson’s disease: A prospective cohort study and genetic analysis
    Chunyu Li, Bin Ke, Jianhai Chen, Yi Xiao, Shichan Wang, Rirui Jiang, Xiaoting Zheng, Junyu Lin, Jingxuan Huang, Huifang Shang · 2024 · Brain Behavior and Immunity
73. An exome study of Parkinson’s disease in Sardinia, a Mediterranean genetic isolate
    Marialuisa Quadri, Xu Yang, Giovanni Cossu, Simone Olgiati, Valeria Saddi, Guido J. Breedveld, Limei Ouyang, Jingchu Hu, Na Xu, Josja Graafland et al. · 2014 · Neurogenetics
74. Genomic Discoveries and Personalized Medicine in Neurological Diseases
    Li Zhang, Huixiao Hong · 2015 · Pharmaceutics
75. Imputation of DNA Methylation Levels in the Brain Implicates a Risk Factor for Parkinson’s Disease
    Konrad Rawlik, Amy Rowlatt, Albert Tenesa · 2016 · Genetics
76. Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells
    Anna Speidel, Sandra Felk, Peter Reinhardt, Jared L. Sterneckert, Frank Gillardon · 2016 · PLoS ONE
77. Parkinson’s disease: what the model systems have taught us so far
    Swagata Ghatak, Dorit Trudler, Nima Dolatabadi, Rajesh Ambasudhan · 2018 · Journal of Genetics
78. Self-report data as a tool for subtype identification in genetically-defined Parkinson’s Disease
    Ashley R. Winslow, Craig L Hyde, Jemma B. Wilk, Nicholas Eriksson, Paul Cannon, Melissa R. Miller, Warren D. Hirst · 2018 · Scientific Reports
79. Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
    Tina De Wit, Veerle Baekelandt, Evy Lobbestael · 2018 · Molecular Neurobiology
80. Parkinson’s Disease is Associated with Dysregulations of a Dopamine-Modulated Gene Network Relevant to Sleep and Affective Neurobehaviors in the Striatum
    Peng Jiang, Joseph R. Scarpa, Vance Gao, Martha Hotz Vitaterna, Andrew Kasarskis, Fred William Turek · 2019 · Scientific Reports
81. The biochemical basis of interactions between Glucocerebrosidase and alpha‐synuclein in GBA 1 mutation carriers
    Marco Toffoli, Laura Smith, Anthony H.V. Schapira · 2020 · Journal of Neurochemistry
82. Alzheimer’s Disease Genetics: A Dampened Microglial Response?
    Zena K. Chatila, Elizabeth M. Bradshaw · 2021 · The Neuroscientist
83. Lysosomal potassium channels
    Yi Wu, Mengnan Xu, Pingping Wang, Alia Kazim Rizvi Syeda, Peng Huang, Xian‐Ping Dong · 2022 · Cell Calcium
84. The Effects of Variants in the Parkin, PINK1, and DJ-1 Genes along with Evidence for their Pathogenicity
    David N. Hauser, Christopher T. Primiani, Mark Cookson · 2016 · Current Protein and Peptide Science
85. Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
    Pratip Rana, Edian F. Franco, Yug Rao, Khajamoinuddin Syed, Debmalya Barh, Vasco Azevedo, Rommel Thiago Jucá Ramos, Preetam Ghosh · 2019 · International Journal of Molecular Sciences
86. Role of Neuroinflammation in Parkinson Disease: The Enigma Continues
    Shyamal H. Mehta, Caroline M. Tanner · 2016 · Mayo Clinic Proceedings
87. Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk
    Elaine Guo Yan Chew, Zhehao Liu, Zheng Li, Sun Ju Chung, Michelle Mulan Lian, Moses Tandiono, Yue Jing Heng, Ebonne Ng, Louis C.S. Tan, Wee Ling Chng et al. · 2024 · Nature Aging
88. Early developmental origins of cortical disorders modeled in human neural stem cells
    Xoel Mato-Blanco, Suel–Kee Kim, Alexandre Jourdon, Shaojie Ma, Sang-Hun Choi, Alice Maria Giani, Miguel I. Paredes, Andrew T.N. Tebbenkamp, Fuchen Liu, Alvaro Duque et al. · 2025 · Nature Communications
89. Machine learning in Alzheimer’s disease genetics
    Matthew Bracher‐Smith, Federico Melograna, Brittany S. Ulm, Céline Bellenguez, Benjamin Grenier‐Boley, Diane Duroux, Alejo J. Nevado‐Holgado, Peter Holmans, Betty Marije Tijms, Marc Hulsman et al. · 2025 · Nature Communications
90. Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
    Michael A S Jewett, Itzia Jiménez-Ferrer, Maria Swanberg · 2017 · Brain Sciences
91. Targeted exome sequencing identifies five novel loci at genome-wide significance for modulating antidepressant response in patients with major depressive disorder
    Zhi Xu, Chunming Xie, Lu Xia, Yonggui Yuan, Hong Zhu, Xiaofa Huang, Caihua Li, Tao Yu, Xiaoxiao Qu, Fengyu Zhang et al. · 2020 · Translational Psychiatry
92. Nanomedicine against Alzheimer’s and Parkinson’s Disease
    Ankit Tandon, Sangh Jyoti Singh, Rajnish Kumar Chaturvedi · 2020 · Current Pharmaceutical Design
93. Genetic Analysis of Six Transmembrane Protein Family Genes in Parkinson’s Disease in a Large Chinese Cohort
    Yuwen Zhao, Kailin Zhang, Hongxu Pan, Yige Wang, Xiaoxia Zhou, Yaqin Xiang, Qian Xu, Qiying Sun, Jieqiong Tan, Xinxiang Yan et al. · 2022 · Frontiers in Aging Neuroscience
94. omicSynth: An open multi-omic community resource for identifying druggable targets across neurodegenerative diseases
    Chelsea X. Alvarado, Mary B. Makarious, Cory A. Weller, Dan Vitale, Mathew J. Koretsky, Sara Bandrés‐Ciga, Hirotaka Iwaki, Kristin S. Levine, Andrew Singleton, Faraz Faghri et al. · 2024 · The American Journal of Human Genetics
95. Gene Expression Profiling of Post Mortem Midbrain of Parkinson’s Disease Patients and Healthy Controls
    Michele Salemi, Maria Ravo, Giuseppe Lanza, Francesca A. Schillaci, Giovanna Maria Ventola, Giovanna Marchese, Maria Grazia Salluzzo, Graziella Cappelletti, Raffaele Ferri · 2024 · International Journal of Molecular Sciences
96. Genetic variation and pesticide exposure influence blood DNA methylation signatures in females with early-stage Parkinson’s disease
    Samantha L. Schaffner, William Casazza, Fanny Artaud, Chaini Konwar, Sarah M. Merrill, Cloé Domenighetti, Julia Maria Schulze-Hentrich, Suzanne Lesage, Alexis Brice, Jean‐Christophe Corvol et al. · 2024 · npj Parkinson s Disease
97. Genetic Variants in GAPDH Confer Susceptibility to Sporadic Parkinson’s Disease in a Chinese Han Population
    Ling Liu, Nian Xiong, Ping Zhang, Chunnuan Chen, Jinsha Huang, Guoxin Zhang, Xiaoyun Xu, Yan Shen, Zhicheng Lin, Tao Wang · 2015 · PLoS ONE
98. Whole-genome sequencing suggests mechanisms for 22q11.2 deletion-associated Parkinson’s disease
    Nancy J. Butcher, Daniele Merico, Mehdi Zarrei, Lucas Ogura, Christian R. Marshall, Eva W.C. Chow, Anthony Edward Lang, Stephen W. Scherer, Anne S. Bassett · 2017 · PLoS ONE
99. DLG2, but not TMEM229B, GPNMB, and ITGA8 polymorphism, is associated with Parkinson's disease in a Taiwanese population
    Hsiu‐Chuan Wu, Chiung‐Mei Chen, Yi‐Chun Chen, Hon‐Chung Fung, Kuo‐Hsuan Chang, Yih‐Ru Wu · 2017 · Neurobiology of Aging
100. Identify Consistent Cross-Modality Imaging Genetic Patterns via Discriminant Sparse Canonical Correlation Analysis
     Meiling Wang, Wei Shao, Xiaoke Hao, Li Shen, Daoqiang Zhang · 2019 · IEEE Transactions on Computational Biology and Bioinformatics